Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 278 of the 284 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia). High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase colon cancer risk via the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. Hyperactivated glucose uptake and aerobic glycolysis (the Warburg effect) are considered as a one of six hallmarks of cancer, including CRC. However, the role of insulin/IGF-1 signaling during the acquisition of the Warburg metabolic phenotypes by CRC cells is still poorly understood. It most likely results from the interaction of multiple processes, directly or indirectly regulated by IGF-1, such as activation of PI3K/Akt/mTORC, and Raf/MAPK signaling pathways, activation of glucose transporters (e.g., GLUT1), activation of key glycolytic enzymes (e.g., LDHA, LDH5, HK II, and PFKFB3), aberrant expression of the oncogenes (e.g., MYC, and KRAS) and/or overexpression of signaling proteins (e.g., HIF-1, TGF-β1, PI3K, ERK, Akt, and mTOR). This review describes the role of IGF-1 in glucose metabolism in physiology and colorectal carcinogenesis, including the role of the insulin/IGF system in the Warburg effect. Furthermore, current therapeutic strategies aimed at repairing impaired glucose metabolism in CRC are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic illustration of the insulin/IGF-1 system involved in the development and progression of colorectal cancer (CRC) through direct (mitotic effects) and indirect (aerobic glycolysis) activity. [↑,↓-increase (up-regulation)/decrease (down-regulation) expression/level; AMPK-adenosine monophosphate (AMP)-activated protein kinase; CRNDE-colorectal neoplasia differentially expressed gene; GLUT-glucose transporter; GH-R-growth hormone receptor; GRP78-glucose-regulated protein 78; HIF-1α, -β-hypoxia-inducible transcription factor-1α, -β; HK II-hexokinase II; IGF-1-insulin-like growth factor 1; IGFBP-1;-2-IGF binding proteins 1,-2; JAK/STAT3-Janus kinase/signal transducer and activator of transcription; KLK10-kallikrein-related peptidase; LDHA, -5-lactate dehydrogenase A, -5; mKRAS-mutant KRAS gene; mMYC-mutant MYC gene; mTP53-mutant tumor protein 53 gene; PI3K/Akt/mTOR-phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin complex; WAT-white adipose tissue].](https://figures.cochat.ai/paper-figures/f88b765def11457a838eb19e9a83d462/insulin-like-growth-factor-1-igf-1-signaling-in-glucose-metabolism-in-colorectal-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IGF1 and IGF2 have substantial effects on cell proliferation and differentiation and are effective inhibitors of apoptosis [174].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–278 of 278
Pechlivanis, S., Wagner, K., Chang-Claude, J., Hoffmeister, M., Brenner, H., & Försti, A. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2007.10.001 · Cited by 44
Baghdiguian, S., Verrier, B., Gérard, C., & Fantini, J. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90194-z · Cited by 44
A novel miR-206/hnRNPA1/PKM2 axis reshapes the Warburg effect to suppress colon cancer growth
Fu, R., Yang, P., Amin, S., & Li, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.019 · Cited by 43
Passardi, A., Scarpi, E., Tamberi, S., Cavanna, L., Tassinari, D., Fontana, A., Pini, S., Bernardini, I., Accettura, C., Ulivi, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134732 · Cited by 43
Chen, C., Meng, W., Wang, C., Sun, D., Liu, P., Zhong, X., & Yu, W. (2020) · Aging · doi:10.18632/aging.103334 · Cited by 43
From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
Bathe, O. F., & Farshidfar, F. (2014) · Genes · doi:10.3390/genes5030536 · Cited by 43
Vassilakos, G., Lei, H., Yang, Y., Puglise, J. M., Matheny, M. E., Durzyńska, J., Ozery, M., Bennett, K., Spradlin, R. A., Bonanno, H., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800459r · Cited by 42
Warburg effect regulated by amphiregulin in the development of colorectal cancer
Nam, S. O., Yotsumoto, F., Miyata, K., Fukagawa, S., Yamada, H., Kuroki, M., & Miyamoto, S. (2015) · Cancer Medicine · doi:10.1002/cam4.416 · Cited by 41
Saukkonen, T. T., Shojaee‐Moradie, F., Williams, R. M., Amin, R., Yuen, K. C. J., Watts, A., Acerini, C. L., Umpleby, A. M., & Dunger, D. B. (2006) · Diabetes · doi:10.2337/db05-1646 · Cited by 41
Diabetes and prognosis in older persons with colorectal cancer
Luo, J., Lin, H.-C., He, K., & HENDRYX, M. S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.68 · Cited by 41
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer
Muc‐Wierzgoń, M., Nowakowska-Zajdel, E., Dzięgielewska-Gęsiak, S., Kokot, T., Klakla, K., Fatyga, E., Grochowska-Niedworok, E., Waniczek, D., & Wierzgoń, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9759 · Cited by 40
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations
Janssen, J. A. M. J. L. (2020) · Cells · doi:10.3390/cells9040862 · Cited by 39
Wong, M. H. T., Holst, C., Astrup, A. V., Handjieva‐Darlenska, T., Jebb, S. A., Kafatos, A., Kunešová, M., Larsen, T. M., Martínez, J. A., Pfeiffer, A. F. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042858 · Cited by 38
Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer
Jiang, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i6.1608 · Cited by 38
Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells
Xu, Y., Han, S., Lei, K., Chang, X., Wang, K., Zhou, L., & Liu, J. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000205 · Cited by 38
Arginine induces IGF-1 secretion from the endoplasmic reticulum
Tsugawa, Y., Handa, H., & Imai, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.044 · Cited by 37
Dworakowska, D., & Grossman, A. B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00390 · Cited by 36
Maximchik, P. V., Abdrakhmanov, A., Inozemtseva, E., Tyurin‐Kuzmin, P. A., Zhivotovsky, B., & Gogvadze, V. G. (2018) · FEBS Journal · doi:10.1111/febs.14687 · Cited by 35
de Kort, S., Simons, C. C. J. M., van den Brandt, P. A., Janssen-Heijnen, M. L. G., Sanduleanu, S., Masclee, A., & Weijenberg, M. P. (2019) · International Journal of Cancer · doi:10.1002/ijc.32365 · Cited by 35
Han, J., Zhao, Z., Zhang, N., Yang, Y., Ma, L., Li, F., Zhang, X., Zuo, J., Fan, Z., Wang, Y., et al. (2021) · Aging · doi:10.18632/aging.202414 · Cited by 35
Insulin and GH–IGF-I axis: endocrine pacer or endocrine disruptor?
Giustina, A., Berardelli, R., Gazzaruso, C., & Mazziotti, G. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0635-6 · Cited by 34
In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J. Ł., Krenács, T., Hamar, P., Gamian, A., Szeja, W., Szkudlarek, D., Krawczyk, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041748 · Cited by 34
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer
Vergati, M., Krasniqi, E., Monte, G. D., Riondino, S., Vallone, D., Guadagni, F., Ferroni, P., & Roselli, M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170116122915 · Cited by 34
Chen, Y.-C., Ou, M.-C., Fang, C.-W., Lee, T., & Tzeng, S. (2019) · Cells · doi:10.3390/cells8040326 · Cited by 33
Mitov, M. I., Harris, J. W., Alstott, M. C., Zaytseva, Y. Y., Evers, B. M., & Butterfield, D. A. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.046 · Cited by 33
Goya, L., de la Puente, A., Ramos, S., Martín, M. Á., Escrivá, F., & Pascual-Leone, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24633 · Cited by 33
Wei, H., Dong, C., & Shen, Z. (2020) · Neoplasma · doi:10.4149/neo_2020_190814n758 · Cited by 33
Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages
Kanbur, N., Derman, O., & Kinik, E. (2004) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2004.2827 · Cited by 33
Regulation of IGF-I and -II by Insulin in Primary Cultures of Fetal Rat Hepatocytes
Goya, L., de la Puente, A., Ramos, S., Martín, M. Á., Escrivá, F., Álvarez, C., & Pascual-Leone, A. M. (2001) · Endocrinology · doi:10.1210/endo.142.12.8521 · Cited by 32
Effects of calorie restriction and weight loss on glucose and insulin levels in obese humans.
Atkinson, R. L., & Kaiser, D. L. (1985) · Journal of the American College of Nutrition · doi:10.1080/07315724.1985.10720084 · Cited by 32
Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?
Dutta, P. R., Bhansali, A. K., Vaiphei, K., Dutta, U., Kumar, P. R., Masoodi, S. R., Mukherjee, K. K., Varma, A., & Kochhar, R. K. (2011) · Pituitary · doi:10.1007/s11102-011-0300-9 · Cited by 31
Kasprzak, A., & Szaflarski, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196995 · Cited by 30
Self-citationUpdate on new GH-IGF axis genetic defects
Vasques, G. A., Andrade, N. L. M. D., Correa, F. A., & Jorge, A. A. L. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000191 · Cited by 30
Metabolic effects of IGF-I deficiency: lessons from mouse models.
Yakar, S., Sun, H., Zhao, H., Pennisi, P. A., Toyoshima, Y., Setser, J., STANNARD, B. S., Scavo, L. M., & LeRoith, D. (2005) · PubMed · Cited by 30
Zhang, Q.-Y., Wang, L., Song, Z., & Qu, X. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.05.004 · Cited by 29
Yamamoto, M., Fukuoka, H., Iguchi, G., Matsumoto, R., Takahashi, M., Nishizawa, H., Suda, K., Bando, H., & Takahashi, Y. (2014) · Pituitary · doi:10.1007/s11102-014-0580-y · Cited by 29
Yamamoto, N., Oshima, T., Yoshihara, K., Aoyama, T., Hayashi, T., Yamada, T., Sato, T., Shiozawa, M., Yoshikawa, T., Morinaga, S., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.5936 · Cited by 29
Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue
Kasprzak, A. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1706 · Cited by 28
Self-citationBiochemical/metabolic changes associated with hepatocellular carcinoma development in mice
El‐Ashmawy, N. E., El‐Bahrawy, H. A., Shamloula, M. M., & El-Feky, O. A. (2014) · Tumor Biology · doi:10.1007/s13277-014-1714-6 · Cited by 28
New Modulators for IGF-I Activity within IGF-I Processing Products
Brisson, B. K., & Barton, E. R. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00042 · Cited by 26
Defining human insulin-like growth factor I gene regulation
Mukherjee, A., Alzhanov, D., & Rotwein, P. S. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00212.2016 · Cited by 26
Кушлинский, Н. Е., Герштейн, Е. С., Николаев, А. А., Delektorskaya, V. V., Korotkova, E. A., Дворова, Е. К., & Ивановна, К. О. (2014) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-014-2425-0 · Cited by 25
Microbial Oncotarget: Bacterial-Produced Butyrate, Chemoprevention and Warburg Effect
Donohoe, D. R., Curry, K. P., & Bultman, S. J. (2013) · Oncotarget · doi:10.18632/oncotarget.915 · Cited by 23
Karimi, K., Mahmoudi, T., Karimi, N., Dolatmoradi, H., Arkani, M., Farahani, H., Vahedi, M., Parsimehr, E., Dabiri, R., Nobakht, H., et al. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5011 · Cited by 23
Kitazawa, M., Hatta, T., Sasaki, Y., Fukui, K., Ogawa, K., Fukuda, E., Goshima, N., Okita, N. T., Yamada, Y., Nakagama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14275 · Cited by 22
Glucose-Regulated Protein 94 (GRP94): A Novel Regulator of Insulin-Like Growth Factor Production
Argon, Y., Bresson, S. E., Marzec, M., & Grimberg, A. (2020) · Cells · doi:10.3390/cells9081844 · Cited by 22
mRNA Expression of IGF-1 and IGF-1R in Patients with Colorectal Adenocarcinoma and Type 2 Diabetes
Liu, R., Hu, L., Sun, A., Cao, Y., Tang, T., Zhang, X.-P., & Zhang, Q. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.04.003 · Cited by 20
Walkiewicz, K. W., Nowakowska‐Zajdel, E., Kozieł, P., & Muc‐Wierzgoń, M. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.74881 · Cited by 20
Leukocyte IGF-1 Receptor Expression during Muscle Recovery
Fragala, M. S., Jajtner, A. R., Townsend, J. R., Gonzalez, A. M., Wells, A. J., Oliveira, L., Hoffman, J. R., Stout, J. R., & Fukuda, D. H. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000392 · Cited by 20
Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort
Park, H., Cho, S., Woo, H., Park, S. K., Shin, H., Chang, S.-H., Yoo, K., & Shin, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188465 · Cited by 20
Mizuno, Y., Hattori, K., Taniguchi, K., Tanaka, K., Uchiyama, K., & Hirose, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11390 · Cited by 19
Pasanisi, P., Gargano, G., Mauro, M. G. D., Cortellini, M., Casagrande, A., Villarini, A., Bruno, E., Roveda, E., Saibene, G., Venturelli, E., et al. (2017) · Tumori Journal · doi:10.5301/tj.5000599 · Cited by 19
Bianda, T., Hussain, M. A., Keller, A., Glatz, Y., Schmitz, O., Christiansen, J. S., Alberti, K. G. M. M., & Froesch, E. R. (1996) · Diabetologia · doi:10.1007/bf00403916 · Cited by 18
Battistone, M. F., Miragaya, K., Rogozinski, A., de Agüero, M. B. G., Alfieri, A., Ballarino, M. C., Boero, L. E., Danilowicz, K., Diez, S., Donoso, M., et al. (2020) · Pituitary · doi:10.1007/s11102-020-01090-8 · Cited by 18
Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Thent, Z. C., Zaidun, N. H., Azmi, M. F., Senin, M., Haslan, H., & Salehuddin, A. R. (2016) · Current Drug Targets · doi:10.2174/1389450118666161205125548 · Cited by 18
Pan, X., Jin, F., Zhu, Z., Yao, L., Ma, S., Bo, H., & Zhang, G. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13786 · Cited by 18
Cao, H., Jin, C., HUANG, D., LIU, C., Sun, D., Tan, C. P. B., Zhu, X., & FEI, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1339 · Cited by 18
C57BL/KsJ-db/db-ApcMin/+ Mice Exhibit an Increased Incidence of Intestinal Neoplasms
Hata, K., Kubota, M., Shimizu, M., Moriwaki, H., Kuno, T., Tanaka, T., Hara, A., & Hirose, Y. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12118133 · Cited by 17
Guidelines versus real life practice: the case of colonoscopy in acromegaly
Parolin, M., Dassie, F., Russo, L., Mazzocut, S., Ferrata, M., Carlo, E. D., Mioni, R., Fallo, F., Vettor, R., Martini, C., et al. (2017) · Pituitary · doi:10.1007/s11102-017-0841-7 · Cited by 17
Ding, J., Li, C., Tang, J., Cheng, Y., Liu, J., & Qiu, M. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0065-6 · Cited by 17
Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly
Cheng, S., Al‐Agha, R., Araújo, P. B., Serri, O., Asa, S. L., & Ezzat, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073543 · Cited by 17
Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development
Stanilov, N., Karakolev, I., Deliysky, T. S., Jovchev, J. P., & Stanilova, S. A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3708-2 · Cited by 16
Adamek, A., Kasprzak, A., MIKOŒ, H., Przybyszewska, W., Seraszek‐Jaros, A., Czajka, A., Sterzyńska, K., & Mozer‐Lisewska, I. (2013) · Oncology Reports · doi:10.3892/or.2013.2546 · Cited by 15
Self-citationPhysical Activity and Risk of Colon Cancer in Diabetic and Nondiabetic US Adults
Schmid, D., Behrens, G., Matthews, C. E., & Leitzmann, M. F. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.017 · Cited by 15
Hu, J., Liu, X., Chi, J., Che, K., Feng, Y., Zhao, S., Wang, Z., & Wang, Y. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170942 · Cited by 15
Impairment of GH/IGF-1 Axis in the Liver of Patients with HCV-Related Chronic Hepatitis
Carotti, S., Guarino, M. P. L., Valentini, F., Porzio, S., Gentilucci, U. V., Perrone, G., Zingariello, M., Gallo, P., Cicala, M., Picardi, A., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118911 · Cited by 14
Sodium Glucose Co-transporter Inhibitors in Patients with Acromegaly and Diabetes
Zaina, A. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.11.007 · Cited by 14
Fołtyn, W., Kos‐Kudła, B., Strzelczyk, J., Matyja, V., Karpe, J., Rudnik, A., Marek, B., Kajdaniuk, D., Sieroń, A. L., & Latos, W. (2008) · PubMed · Cited by 14
Franklin, C. C., Chin, P. C., Turner, J. T., & Kim, H. D. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90103-6 · Cited by 14
Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism
Redwan, E. M. M. M., Linjawi, M. H., & Uversky, V. N. (2016) · Scientific Reports · doi:10.1038/srep23320 · Cited by 13
Epithelial insulin receptor expression-prognostic relevance in colorectal cancer
Heckl, S. M., Pellinghaus, M., Krüger, S., Bosselmann, C., Wilhelm, F., Behrens, H., Schreiber, S., & Röcken, C. (2018) · Oncotarget · doi:10.18632/oncotarget.26490 · Cited by 12
Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors
Aguilera, Ó., & Serna‐Blasco, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-02771-1_3 · Cited by 11
Jain, D., Chhoda, A., & Uribe, J. (2016) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9842-4 · Cited by 11
Impact of Glucose Metabolism Disorders on IGF-1 Levels in Patients with Acromegaly
Doğanşen, S. Ç., Yalın, G. Y., Tanrıkulu, S., & Yarman, S. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0594-2404 · Cited by 11
Han, X., Hou, S., & Yang, A. (2016) · Medical Science Monitor · doi:10.12659/msm.895837 · Cited by 9
Insulin: A Growth Hormone and Potential Oncogene.
Laron, Z., & Werner, H. (2020) · PubMed · doi:10.17458/per.vol17.2020.lw.insulinghpotentialoncogene · Cited by 8
Franklin, C. C., Chin, P. C., Turner, J. T., & Kim, H. D. (1988) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(88)80093-8 · Cited by 7
What is the gut feeling telling us about physical activity in colorectal carcinogenesis?
Berković, M. C., Cigrovski, V., Bilić-Čurčić, I., & Mrzljak, A. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i23.5844 · Cited by 5
Cited by
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Metabolic reprogramming consequences of sepsis: adaptations and contradictions
Liu, J., Zhou, G., Wang, X., & Liu, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04490-0 · Cited by 179
Dai, F., Zhang, J., Chen, F., Chen, X., Lee, C. J., Liang, H., Zhao, L., & Tan, H. F. (2024) · Advanced Science · doi:10.1002/advs.202408783 · Cited by 164
Targeting of the tumor immune microenvironment by metformin
Wu, Z., Zhang, C., & Najafi, M. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00648-w · Cited by 83
Screening for Coronary Artery Disease in Cancer Survivors
Velusamy, R., Nolan, M. T., Murphy, A. J., Thavendiranathan, P., & Marwick, T. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.007 · Cited by 90
Metadata
- Authors
- Kasprzak, A.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Kasprzak, Aldona
- ORCID
- Kasprzak, Aldona
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-16
- Volume
- 22
- Issue
- 12
- Pages
- 6434
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8234711
- OpenAlex
- W3169775278
- Cited by
- 248
- References
- 284
- Citations by year
- 2026: 51 · 2025: 73 · 2024: 60 · 2023: 32 · 2022: 22 · 2021: 10
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- insulin-like growth factor I, colorectal cancer, glucose metabolism, Warburg effect, aerobic glycolysis, metabolic syndrome, hyperglycemia, PI3K/AKT/mTOR pathway, glucose transporters, GLUT1, glycolytic enzymes, c-Myc, KRAS, HIF-1, TGF-β1, colorectal carcinogenesis
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Disease Susceptibility, Glucose, Humans, Insulin-Like Growth Factor I, Metabolic Diseases, Risk Factors, Colorectal Neoplasms, Signal Transduction, Biomarkers, Gene Expression Regulation, Neoplastic, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.